The integration of immunohistochemical (IHC) profiling, highlighting markers such as CK7, CD117, and AMACR, not only strengthened the diagnostic accuracy of subtypes but also facilitated the correlation between tumor biology and clinical behavior. Here, KIT is linked to neoplasm.